Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00315978 · ClinicalTrials.gov registry record · NA

The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention

A NA study of Cardiovascular Disease, sponsored by University of North Carolina.

Completed
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT00315978: Completed NA study of Cardiovascular Disease, sponsored by University of North Carolina.

NCT00315978 is a NA study of Cardiovascular Disease that has completed, run by University of North Carolina. The registered enrollment target is 120 participants, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00315978, a NA study of Cardiovascular Disease, has completed, sponsored by University of North Carolina.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.

Conditions Studied

Interventions

  • DEVICE Heart-to-Heart Decision Aid

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2003-06
Est. Completion 2004-02
Phase NA
University of North Carolina

14 total trials

What the finished NCT00315978 record still lists

NCT00315978 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,697-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Cardiovascular Disease appearing as the primary indexed condition, and to 1 intervention - of which Heart-to-Heart Decision Aid is the first listed.

NCT00315978 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT00315978 about?

NCT00315978 is a clinical study titled "The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention". The purpose of this study is to determine whether providing patients with information about their global coronary heart disease (CHD) risk and effective risk-reducing strategies allows them to make appropriate decisions about heart disease prevention.

What is the current status of trial NCT00315978?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2003-06. Estimated completion is 2004-02.

What conditions does trial NCT00315978 study?

This clinical trial studies the following conditions: Cardiovascular Disease.

What interventions are being tested in trial NCT00315978?

The interventions under investigation include: Heart-to-Heart Decision Aid (DEVICE).

Who is sponsoring clinical trial NCT00315978?

This trial is sponsored by University of North Carolina, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00315978 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00315978's enrollment target sits among peer trials

120 68th of 137 higher than 68 of 137 other Cardiovascular Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00315978, the US trial registry maintained by the National Library of Medicine. NCT00315978 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.